Ally Bridge Group »

Mind Medicine Mindmed shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Mind Medicine Mindmed (MNMD) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Mind Medicine Mindmed

Tip: Access up to 7 years of quarterly data

All positions including Mind Medicine Mindmed held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mind Medicine Mindmed by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.4M 1.0M 9.40

More positions owned by Ally Bridge Group

Blueprint Medicines (BPMC)
Soleno Therapeutics (SLNO)
Cg Oncology (CGON)
Xenon Pharmaceuticals (XENE)
Verona Pharma Sponsored Ads (VRNA)
Merus N V (MRUS)
Praxis Precision Medicines I (PRAX)
Mind Medicine Mindmed Com New (MNMD)
Avadel Pharmaceuticals Sponsored Adr
Geron Corporation (GERN)
Jasper Therapeutics Com New (JSPR)
Kura Oncology (KURA)
Insmed Com Par $.01 (INSM)
Dianthus Therapeutics (DNTH)
Olema Pharmaceuticals (OLMA)

View all positions for Ally Bridge Group

Top funds holding Mind Medicine Mindmed

Commodore Capital
Deep Track Capital
BlackRock
BlackRock
Blackstone Group
Driehaus Capital Management
Octagon Capital Advisors
Marshall Wace
State Street Corporation
Vanguard Group
Geode Capital Management
Woodline Partners
AWM Investment Company
Two Sigma Investments
Northern Trust

View all funds holding Mind Medicine Mindmed